Abstract
Protease-activated receptor-2 (PAR-2) is activated by serine proteases, such as trypsin and mast cell tryptase. Recently, we have shown that activators of PAR-2 contract the rat urinary bladder mainly by stimulating release of prostaglandins (PGs) from the mucosal layer. In the present study, we investigated how the PAR-2-mediated responses are altered in rats with cyclophosphamide (CYP)-induced cystitis. The contractile responses to trypsin and PAR-2 activating peptide (PAR-2 AP; SLIGRL-NH2) in the urinary bladders were augmented by treatment of rats with CYP. The contractile effects of these PAR-2 activators on the smooth muscles of the urinary bladder were also potentiated after induction of cystitis by CYP. On the other hand, CYP-induced cystitis significantly attenuated contractions produced by PGE2 in the smooth muscles of the urinary bladder. The PAR-2-mediated contractions were significantly prevented by indomethacin or NS-398, an inhibitor of cyclooxygenase-2. Both trypsin and PAR-2 AP increased the release of PGE2 from the urinary bladder mucosa and smooth muscle. CYP-induced cystitis enhanced the PAR-2 activators-induced PGE2 releases from the urinary mucosa without affecting those from the smooth muscle of the urinary bladder. The PGE2 releases were prevented by indomethacin or NS-398. The mRNAs for PAR-2 in the urinary bladder mucosa and smooth muscle preparations were not altered in CYP-induced cystitis. These results suggest that PAR-2-mediated responses were enhanced in bladders from CYP-treated rats. The enhancement of PAR-2-mediated contraction might be ascribed to the increased production of PGs and the altered sensitivity of smooth muscle to PAR-2 activators.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bon K, Lanteri-Minet M, de Pommery J, Michiels JF, Menetrey D (1996) Cyclophosphamide cystitis as a model of visceral pain in rats. A survey of hindbrain structures involved in visceroception and nociception using the expression of c-Fos and Krox-24 proteins. Exp Brain Res 108:404–416
Boucher M, Meen M, Codron JP, Coudore F, Kemeny JL, Eschalier A (2000) Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. J Urol 164:203–208
Boucher W, el-Mansoury M, Pang X, Sant GR, Theoharides TC (1995) Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol 76:94–100
Bultitude MI, Hills NH, Shuttleworth KE (1976) Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br J Urol 48:631–637
Cocks TM, Moffatt JD (2000) Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 21:103–108
Cox PJ (1979) Cyclophosphamide cystitis and bladder cancer. A hypothesis. Eur J Cancer 15:1071–1072
D’Andrea MR, Saban MR, Nguyen NB, Andrade-Gordon P, Saban R (2003) Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder. Am J Pathol 162:907-923
Déry O, Corvera CU, Steinhoff M, Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274:C1429–C1452
Fiorucci S, Distrutti E (2002) Role of PAR2 in pain and inflammation. Trends Pharmacol Sci 23:153–155
Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55–59
Grinberg-Funes DJ, Sheldon C, Weiss M (1990) The use of prostaglandin F2 alpha for the prophylaxis of cyclophosphamide induced cystitis in rats. J Urol 144:1500–1504
Hollenberg MD, Compton SJ (2002) International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors. Pharmacol Rev 54:203–217
Hu VY, Malley S, Dattilio A, Folsom JB, Zvara P, Vizzard MA (2003) COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am J Physiol Regul Integr Comp Physiol 284:R574–R585
Kubota Y, Nakahara T, Mitani A, Maruko T, Saito M, Sakamoto K, Ishii K (2003) Possible involvement of Ca2+-independent phospholipase A2 in protease-activated receptor-2-mediated contraction of rat urinary bladder. Naunyn-Schmiedebergs Arch Pharmacol 367:588–591
Lanteri-Minet M, Bon K, de Pommery J, Michiels JF, Menetrey D (1995) Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 105:220–232
Lecci A, Birder LA, Meini S, Catalioto RM, Tramontana M, Giuliani S, Criscuoli M, Maggi CA (2000) Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats. Br J Pharmacol 130:331–338
Maggi CA (1992) Prostanoids as local modulators of reflex micturition. Pharmacol Res 25:13–20
Maggi CA, Giuliani S, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A (1988) Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents. Eur J Pharmacol 145:105–112
Maggi CA, Lecci A, Santicioli P, Del Bianco E, Giuliani S (1992) Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J Auton Nerv Syst 38:201–208
Meini S, Lecci A, Cucchi P, Catalioto RM, Criscuoli M, Maggi CA (1998) Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. J Pharmacol Exp Ther 287:137–143
Nakahara T, Kubota Y, Mitani A, Maruko T, Sakamoto K, Ishii K (2003) Protease-activated receptor-2-mediated contraction in the rat urinary bladder: the role of urinary bladder mucosa. Naunyn-Schmiedebergs Arch Pharmacol 367:211–213
Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, Moon TD, Uehling DT, Haak-Frendscho M (1999) Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 161:438–441
Park JM, Yang T, Arend LJ, Smart AM, Schnermann JB, Briggs JP (1997) Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am J Physiol 273:F538–F544
Park JM, Yang T, Arend LJ, Schnermann JB, Peters CA, Freeman MR, Briggs JP (1999) Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch. Am J Physiol 276:F129–F136
Poggesi L, Nicita G, Castellani S, Selli C, Galanti G, Turini D, Masotti G (1980) The role of prostaglandins in the maintenance of the tone of the rabbit urinary bladder. Invest Urol 17:454-458
Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM, Interstitial Cystitis Database Study Group (2001) Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 57 [Suppl 1]:67–81
Wheeler MA, Yoon JH, Olsson LE, Weiss RM (2001) Cyclooxygenase-2 protein and prostaglandin E2 production are up-regulated in a rat bladder inflammation model. Eur J Pharmacol 417:239–248
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakahara, T., Kubota, Y., Saito, M. et al. Protease-activated receptor-2-mediated contraction of urinary bladder is enhanced in cyclophosphamide-treated rats. Naunyn-Schmiedeberg's Arch Pharmacol 369, 212–219 (2004). https://doi.org/10.1007/s00210-003-0847-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0847-8